Desmoid Tumor Research Foundation RFP Grant
Funding Amount
US $65,000
Deadline
Deadline not published
Grant Type
Foundation
Overview
The Desmoid Tumor Research Foundation invites proposals for research into the spontaneous regression of desmoid tumors, which exhibit unpredictable behaviors. This RFP encourages cross-disciplinary collaborations to explore various aspects such as molecular changes, immune system involvement, and biomarkers associated with tumor behavior. By understanding these factors, the aim is to enhance clinical interventions and develop novel therapeutic strategies. Proposals should focus on innovative methods to investigate these critical issues within tumor biology.
Background
Desmoid tumors (also known as aggressive fibromatosis) are locally invasive soft tissue tumors characterized by unpredictable clinical behavior. While some tumors demonstrate aggressive growth requiring surgical or medical intervention, others remain stable or undergo spontaneous regression without therapy. The basis for this regression remains poorly understood. Understanding the mechanisms underlying spontaneous regression could provide critical insights into tumor biology, improve nomination for clinical intervention, and can lead to novel therapeutic strategies that mimic or induce this process.
Purpose
This RFP invites proposals that seek to investigate the factors contributing to spontaneous regression in desmoid tumors. Proposals that foster cross-disciplinary teams are strongly encouraged. The proposals can focus on any discipline, and as examples proposals could explore:
Molecular or cellular changes associated with regression or stable diseaseImmune system and stroma involvement in tumor behaviorTranscriptional and epigenetic profiles of regressing versus progressing tumorsBiomarkers predictive of regression or progressionDevelopment of preclinical models to study spontaneous regressionSystems biology or computational approaches to model regressionLongitudinal clinical or imaging data to identify features of spontaneous regression, with a clear link to underlying biologyHost/tumor interactions
What The Desmoid Tumor Research Foundation actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 1
- Total given
- $10K
- Median grant
- $10K
- By dollars: Massachusetts 100%. Top recipient cities: Cambridge, MA.
Example grants
MIT Koch Institute for Integrative Cancer Research · Cambridge, MA
Planning grant
$10K
Focus Areas & Funding Uses
Fields of Work
- Science research
- Cancer
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
CTNNB1 Research Grant Program
CTNNB1 Connect and Cure Inc
Amount
Varies
Deadline
Rolling
Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
January 11, 2027
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 8, 2027
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
National Institutes of Health
Amount
Up to $500,000
Deadline
January 7, 2028
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $500,000
Deadline
November 22, 2028
Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
July 5, 2029
Ready to apply for Desmoid Tumor Research Foundation RFP Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Desmoid Tumor Research Foundation RFP Grant. Now let's win it.